These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1827015)

  • 1. Effects of isradipine on platelet function in hypertension at rest and during exercise.
    Fitscha P; Virgolini I; Rauscha F; Sinzinger H
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):178S-180S. PubMed ID: 1827015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isradipine improves platelet function in hypertensives.
    Sinzinger H; Virgolini I; Rauscha F; Fitscha P; O'Grady J
    Eur J Clin Pharmacol; 1992; 42(1):43-6. PubMed ID: 1531796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bopindolol on platelet function in hypertension at rest and during exercise.
    Virgolini I; Fitscha P; Rauscha F; Sinzinger H
    Prostaglandins Leukot Essent Fatty Acids; 1990 Jun; 40(2):125-30. PubMed ID: 2143586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does calcium channel blockade and beta-adrenergic blockade affect platelet function and fibrinolysis to a varying degree?
    Gleerup G; Mehlsen J; Winther K
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):87-9. PubMed ID: 7723358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating effect of low-density lipoprotein and its reversal by isradipine.
    Fetkovská N; Fedelesová V; Kozlovský M; Dzúrik R
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):175S-177S. PubMed ID: 1827014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor.
    Gupta RK; Kjeldsen SE; Motley E; Weder AB; Zweifler AJ; Julius S
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):13-9. PubMed ID: 1708046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased fibrinolytic activity and increased platelet function in hypertension. Possible influence of calcium antagonism.
    Gleerup G; Winther K
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):168S-171S. PubMed ID: 1827012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-haemorrhagic effects of calcium antagonists: a comparison of isradipine and atenolol on ex vivo platelet function in hypertensive subjects.
    Smith A; McPherson J; Taylor M; Mason A; Carney S; Gillies A
    J Hum Hypertens; 1997 Dec; 11(12):783-8. PubMed ID: 9468004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effect of isradipine on blood pressure at rest and during exercise.
    Dvorák I; Blaha M; Nĕmcová H
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):144S-146S. PubMed ID: 1673616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aprotinin on prostaglandin metabolism and platelet function in open heart surgery.
    Nagaoka H; Innami R; Murayama F; Funakoshi N; Hirooka K; Watanabe M; Satoh M
    J Cardiovasc Surg (Torino); 1991; 32(1):31-7. PubMed ID: 1707053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the calcium antagonist isradipine on 24-hour ambulatory blood pressure, platelet aggregation, and neutrophil oxygen free radicals in hypertension.
    Ding YA; Han CL; Chou TC; Lai WY; Shiao MF
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S32-7. PubMed ID: 1376832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin and platelet activation during treatment with isradipine.
    Fetkovska N; Sebekova K; Fedelesova V; Dzurik R
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S31-3. PubMed ID: 1720482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sodium restriction on platelet function in patients with essential hypertension.
    Ikeda T; Gomi T; Sakurai J; Toya Y; Fujinami K; Yuhara M; Ikegami F
    Jpn Heart J; 1989 May; 30(3):365-73. PubMed ID: 2529381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
    Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
    Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of felodipine-ER on blood pressure, platelet function, and rheological properties in hypertension.
    Chou TZ; Lee KW; Ding YA
    Can J Cardiol; 1993 Jun; 9(5):423-7. PubMed ID: 8394193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a sustained thromboxane synthase inhibition on exercise-induced changes in eicosanoid formation, catecholamine concentration, and platelet aggregation in humans.
    Ohnishi A; Ishizaki T; Echizen H; Yasuda K; Fujiwara H; Tanaka T
    Clin Pharmacol Ther; 1992 Apr; 51(4):454-64. PubMed ID: 1563215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of felodipine, a new calcium channel antagonist, on platelet function and fibrinolytic activity at rest and after exercise.
    Sengeløv H; Winther K
    Eur J Clin Pharmacol; 1989; 37(5):453-7. PubMed ID: 2532135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease.
    Fujinishi A; Takahara K; Ohba C; Nakashima Y; Kuroiwa A
    Angiology; 1997 Jun; 48(6):515-21. PubMed ID: 9194537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vitamin E administration on platelet function in diabetes mellitus.
    Kunisaki M; Umeda F; Inoguchi T; Watanabe J; Nawata H
    Diabetes Res; 1990 May; 14(1):37-42. PubMed ID: 2134664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.